13th Mar 2007 17:46
GlaxoSmithKline PLC13 March 2007 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, PersonsDischarging Managerial Responsibility or Connected Persons in the OrdinaryShares and Ordinary Share ADRs ("ADRs") of GlaxoSmithKline plc. 12 March 2007 Abacus (GSK) Trustees Limited, as trustee of the GlaxoSmithKline Employee Trust ("the GSK Trust"), transferred 19,933 Ordinary Shares in the Company to participants in the SmithKline Beecham Employee Share Option Plan 1991. The GSK Trust sold 11,326 American Depositary Receipts (ADRs) in the Company on behalf of participants in the SmithKline Beecham Mid-Term Incentive Plan at a price of $55.49 per ADR. The GSK Trust transferred 19,988 ADRs in the Company to participants in the SmithKline Beecham Mid-Term Incentive Plan. The Company was advised of these transactions on 13 March 2007. The GSK Trust is a discretionary trust of which all employees or formeremployees of GlaxoSmithKline plc and its subsidiaries are potentialbeneficiaries. Three of the Company's directors, Dr J-P Garnier, Dr M M Slaouiand Mr J S Heslop are therefore interested in the shares held in the GSK Trustfrom time to time in the same way as other employees or former employees ofGlaxoSmithKline plc and its subsidiaries. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(b). S M BicknellCompany Secretary 13 March 2007 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline